Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reexamination Certificate
2005-02-23
2009-06-09
Chemyshev, Olga N (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
C530S300000, C424S185100, C424S193100, C435S069100
Reexamination Certificate
active
07544771
ABSTRACT:
Embodiments are directed to a peptide and protein containing that peptide, nucleic acids, antibodies, as well assays detecting the peptide or protein, and methods of identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases.
REFERENCES:
patent: 5830670 (1998-11-01), de la Monte et al.
patent: 5948634 (1999-09-01), de la Monte et al.
patent: 5948888 (1999-09-01), de la Monte et al.
patent: 6770797 (2004-08-01), Wands et al.
patent: 2002/0104108 (2002-08-01), De La Monte et al.
patent: 2002/0129391 (2002-09-01), De La Monte et al.
patent: 2003/0033621 (2003-02-01), De La Monte et al.
patent: 2003/0054990 (2003-03-01), Averback
patent: 2003/0066097 (2003-04-01), Monte et al.
patent: WO 98/38204 (1998-09-01), None
Averback Paul
Gemmell Jack
Chemyshev Olga N
Goodwin & Procter LLP
Nymox Corporation
LandOfFree
Protein and its use in diagnosing Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein and its use in diagnosing Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein and its use in diagnosing Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083143